학술논문
A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia
Document Type
Article
Author
Source
In: Alzheimer's and Dementia: Translational Research and Clinical Interventions . (Alzheimer's and Dementia: Translational Research and Clinical Interventions, 2022, 8(1))
Subject
Language
English
ISSN
23528737